Skip to main content
Top
Published in: Current Rheumatology Reports 1/2013

01-01-2013 | CRYSTAL ARTHRITIS (MH PILLINGER, SECTION EDITOR)

Dual-Energy Computed Tomography for Gout Diagnosis and Management

Authors: Nicola Dalbeth, Hyon K. Choi

Published in: Current Rheumatology Reports | Issue 1/2013

Login to get access

Abstract

The central feature of gout is deposition of monosodium urate crystals. Dual-energy computed tomography (DECT) is a recently developed advanced imaging method that enables visualisation of urate deposits by analysis of the chemical composition of the scanned materials. This review summarises recent research describing the use of DECT in gout management. This technology may assist in both diagnosis and monitoring of the disease. Studies of patients with established disease indicate diagnostic accuracy for gout is high. Excellent inter-reader agreement has been reported for detection of urate deposits by use of DECT. Automated volume assessment software also enables rapid and reproducible measurement of urate deposits within tophi, suggesting that this modality may be useful for monitoring the disease. Although several case reports indicate DECT can be used to reveal reduction in the size of urate deposits, the sensitivity to change in response to urate-lowering therapy has not yet been systematically reported. DECT images reveal variable urate deposition within tophi of the same physical size. The ability to visualise urate deposits in tissue may provide new insights into the pathology and mechanisms of gout.
Literature
1.
go back to reference Loeb JN. The influence of temperature on the solubility of monosodium urate. Arthritis Rheum. 1972;15(2):189–92.PubMedCrossRef Loeb JN. The influence of temperature on the solubility of monosodium urate. Arthritis Rheum. 1972;15(2):189–92.PubMedCrossRef
2.
go back to reference Dalbeth N, Pool B, Gamble GD, Smith T, Callon KE, McQueen FM, et al. Cellular characterization of the gouty tophus a quantitative analysis. Arthritis Rheum. 2010;62(5):1549–56.PubMedCrossRef Dalbeth N, Pool B, Gamble GD, Smith T, Callon KE, McQueen FM, et al. Cellular characterization of the gouty tophus a quantitative analysis. Arthritis Rheum. 2010;62(5):1549–56.PubMedCrossRef
3.
go back to reference Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, et al. Eular evidence based recommendations for gout. Part ii: management. Report of a task force of the eular standing committee for international clinical studies including therapeutics (escisit). Ann Rheum Dis. 2006;65(10):1312–24.PubMedCrossRef Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, et al. Eular evidence based recommendations for gout. Part ii: management. Report of a task force of the eular standing committee for international clinical studies including therapeutics (escisit). Ann Rheum Dis. 2006;65(10):1312–24.PubMedCrossRef
4.
go back to reference Shoji A, Yamanaka H, Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum. 2004;51(3):321–5.PubMedCrossRef Shoji A, Yamanaka H, Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum. 2004;51(3):321–5.PubMedCrossRef
5.
go back to reference Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum. 2002;47(4):356–60.PubMedCrossRef Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum. 2002;47(4):356–60.PubMedCrossRef
6.
go back to reference Nicolaou S, Yong-Hing CJ, Galea-Soler S, Hou DJ, Louis L, Munk P. Dual-energy ct as a potential new diagnostic tool in the management of gout in the acute setting. AJR Am J Roentgenol. 2010;194(4):1072–8.PubMedCrossRef Nicolaou S, Yong-Hing CJ, Galea-Soler S, Hou DJ, Louis L, Munk P. Dual-energy ct as a potential new diagnostic tool in the management of gout in the acute setting. AJR Am J Roentgenol. 2010;194(4):1072–8.PubMedCrossRef
7.
go back to reference Primak AN, Fletcher JG, Vrtiska TJ, Dzyubak OP, Lieske JC, Jackson ME, et al. Noninvasive differentiation of uric acid versus non-uric acid kidney stones using dual-energy ct. Acad Radiol. 2007;14(12):1441–7.PubMedCrossRef Primak AN, Fletcher JG, Vrtiska TJ, Dzyubak OP, Lieske JC, Jackson ME, et al. Noninvasive differentiation of uric acid versus non-uric acid kidney stones using dual-energy ct. Acad Radiol. 2007;14(12):1441–7.PubMedCrossRef
8.
go back to reference Graser A, Johnson TR, Bader M, Staehler M, Haseke N, Nikolaou K, et al. Dual energy ct characterization of urinary calculi: initial in vitro and clinical experience. Invest Radiol. 2008;43(2):112–9.PubMedCrossRef Graser A, Johnson TR, Bader M, Staehler M, Haseke N, Nikolaou K, et al. Dual energy ct characterization of urinary calculi: initial in vitro and clinical experience. Invest Radiol. 2008;43(2):112–9.PubMedCrossRef
9.
go back to reference Manglaviti G, Tresoldi S, Guerrer CS, Di Leo G, Montanari E, Sardanelli F, et al. In vivo evaluation of the chemical composition of urinary stones using dual-energy ct. AJR Am J Roentgenol. 2011;197(1):W76–83.PubMedCrossRef Manglaviti G, Tresoldi S, Guerrer CS, Di Leo G, Montanari E, Sardanelli F, et al. In vivo evaluation of the chemical composition of urinary stones using dual-energy ct. AJR Am J Roentgenol. 2011;197(1):W76–83.PubMedCrossRef
10.
go back to reference Thomas C, Heuschmid M, Schilling D, Ketelsen D, Tsiflikas I, Stenzl A, et al. Urinary calculi composed of uric acid, cystine, and mineral salts: differentiation with dual-energy ct at a radiation dose comparable to that of intravenous pyelography. Radiology. 2010;257(2):402–9.PubMedCrossRef Thomas C, Heuschmid M, Schilling D, Ketelsen D, Tsiflikas I, Stenzl A, et al. Urinary calculi composed of uric acid, cystine, and mineral salts: differentiation with dual-energy ct at a radiation dose comparable to that of intravenous pyelography. Radiology. 2010;257(2):402–9.PubMedCrossRef
11.
go back to reference Johnson TR, Weckbach S, Kellner H, Reiser MF, Becker CR. Clinical image: dual-energy computed tomographic molecular imaging of gout. Arthritis Rheum. 2007;56(8):2809.PubMedCrossRef Johnson TR, Weckbach S, Kellner H, Reiser MF, Becker CR. Clinical image: dual-energy computed tomographic molecular imaging of gout. Arthritis Rheum. 2007;56(8):2809.PubMedCrossRef
12.
go back to reference • Choi HK, Al-Arfaj AM, Eftekhari A, Munk PL, Shojania K, Reid G, et al. Dual energy computed tomography in tophaceous gout. Ann Rheum Dis. 2009;68(10):1609–12. The first study of DECT in patients with gout, demonstrating that DECT can detect a large number of urate deposits that are not apparent on clinical assessment. Excellent sensitivity and specificity was also reported for tophaceous gout. • Choi HK, Al-Arfaj AM, Eftekhari A, Munk PL, Shojania K, Reid G, et al. Dual energy computed tomography in tophaceous gout. Ann Rheum Dis. 2009;68(10):1609–12. The first study of DECT in patients with gout, demonstrating that DECT can detect a large number of urate deposits that are not apparent on clinical assessment. Excellent sensitivity and specificity was also reported for tophaceous gout.
13.
go back to reference Thiele RG, Schlesinger N. Diagnosis of gout by ultrasound. Rheumatology (Oxford). 2007;46(7):1116–21.CrossRef Thiele RG, Schlesinger N. Diagnosis of gout by ultrasound. Rheumatology (Oxford). 2007;46(7):1116–21.CrossRef
14.
go back to reference Grassi W, Meenagh G, Pascual E, Filippucci E. “Crystal clear”-sonographic assessment of gout and calcium pyrophosphate deposition disease. Semin Arthritis Rheum. 2006;36(3):197–202.PubMedCrossRef Grassi W, Meenagh G, Pascual E, Filippucci E. “Crystal clear”-sonographic assessment of gout and calcium pyrophosphate deposition disease. Semin Arthritis Rheum. 2006;36(3):197–202.PubMedCrossRef
15.
go back to reference • Glazebrook KN, Guimaraes LS, Murthy NS, Black DF, Bongartz T, Manek NJ, et al. Identification of intraarticular and periarticular uric acid crystals with dual-energy ct: initial evaluation. Radiology. 2011;261(2):516–24. A retrospective study examining the use of DECT for gout diagnosis, reporting excellent sensitivity and inter-reader agreement.PubMedCrossRef • Glazebrook KN, Guimaraes LS, Murthy NS, Black DF, Bongartz T, Manek NJ, et al. Identification of intraarticular and periarticular uric acid crystals with dual-energy ct: initial evaluation. Radiology. 2011;261(2):516–24. A retrospective study examining the use of DECT for gout diagnosis, reporting excellent sensitivity and inter-reader agreement.PubMedCrossRef
16.
go back to reference •• Choi HK, Burns LC, Shojania K, Koenig N, Reid G, Abufayyah M et al. Dual energy ct in gout: a prospective validation study. Ann Rheum Dis. 2012;71(9):1466–71. A prospective study of DECT for gout diagnosis and monitoring, reporting high specificity for gout, and excellent inter-reader reproducibility for DECT measurement of urate volumes. •• Choi HK, Burns LC, Shojania K, Koenig N, Reid G, Abufayyah M et al. Dual energy ct in gout: a prospective validation study. Ann Rheum Dis. 2012;71(9):1466–71. A prospective study of DECT for gout diagnosis and monitoring, reporting high specificity for gout, and excellent inter-reader reproducibility for DECT measurement of urate volumes.
17.
go back to reference Parikh P, Butendieck R, Kransdorf M, Calamia K. Detection of lumbar facet joint gouty arthritis using dual-energy computed tomography. J Rheumatol. 2010;37(10):2190–1.PubMedCrossRef Parikh P, Butendieck R, Kransdorf M, Calamia K. Detection of lumbar facet joint gouty arthritis using dual-energy computed tomography. J Rheumatol. 2010;37(10):2190–1.PubMedCrossRef
18.
go back to reference Desai MA, Peterson JJ, Garner HW, Kransdorf MJ. Clinical utility of dual-energy ct for evaluation of tophaceous gout. Radiographics. 2011;31(5):1365–75. discussion 76–7.PubMedCrossRef Desai MA, Peterson JJ, Garner HW, Kransdorf MJ. Clinical utility of dual-energy ct for evaluation of tophaceous gout. Radiographics. 2011;31(5):1365–75. discussion 76–7.PubMedCrossRef
19.
go back to reference • Manger B, Lell M, Wacker J, Schett G, Rech J. Detection of periarticular urate deposits with dual energy ct in patients with acute gouty arthritis. Ann Rheum Dis. 2012;71(3):470–2. A small study of use of DECT for patients with acute gout, showing that 11/14 patients with acute gout had DECT urate deposits. However, for the four patients presenting with first gout attack, only two had urate deposits present on DECT, raising the possibility that sensitivity may be lower than previously reported for early disease.PubMedCrossRef • Manger B, Lell M, Wacker J, Schett G, Rech J. Detection of periarticular urate deposits with dual energy ct in patients with acute gouty arthritis. Ann Rheum Dis. 2012;71(3):470–2. A small study of use of DECT for patients with acute gout, showing that 11/14 patients with acute gout had DECT urate deposits. However, for the four patients presenting with first gout attack, only two had urate deposits present on DECT, raising the possibility that sensitivity may be lower than previously reported for early disease.PubMedCrossRef
20.
go back to reference Glazebrook KN, Kakar S, Ida CM, Laurini JA, Moder KG, Leng S. False-negative dual-energy computed tomography in a patient with acute gout. J Clin Rheumatol. 2012;18(3):138–41.PubMedCrossRef Glazebrook KN, Kakar S, Ida CM, Laurini JA, Moder KG, Leng S. False-negative dual-energy computed tomography in a patient with acute gout. J Clin Rheumatol. 2012;18(3):138–41.PubMedCrossRef
21.
go back to reference Dalbeth N, Schauer C, Macdonald P, Perez-Ruiz F, Schumacher HR, Hamburger S, et al. Methods of tophus assessment in clinical trials of chronic gout: a systematic literature review and pictorial reference guide. Ann Rheum Dis. 2011;70(4):597–604.PubMedCrossRef Dalbeth N, Schauer C, Macdonald P, Perez-Ruiz F, Schumacher HR, Hamburger S, et al. Methods of tophus assessment in clinical trials of chronic gout: a systematic literature review and pictorial reference guide. Ann Rheum Dis. 2011;70(4):597–604.PubMedCrossRef
22.
go back to reference Dalbeth N, McQueen FM, Singh JA, MacDonald PA, Edwards NL, Schumacher Jr HR, et al. Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities. J Rheumatol. 2011;38(7):1458–61.PubMedCrossRef Dalbeth N, McQueen FM, Singh JA, MacDonald PA, Edwards NL, Schumacher Jr HR, et al. Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities. J Rheumatol. 2011;38(7):1458–61.PubMedCrossRef
23.
go back to reference • Dalbeth N, Aati O, Gao A, House M, Liu Q, Horne A, et al. Assessment of tophus size: a comparison between physical measurement methods and dual-energy computed tomography scanning. J Clin Rheumatol. 2012;18(1):23–7. A prospective study comparing physical measurement of tophi with DECT measurement of urate volume. DECT reproducibility was higher than that of physical measurement. Analysis of the DECT images also revealed variable deposition of urate within tophi of similar sizes.PubMedCrossRef • Dalbeth N, Aati O, Gao A, House M, Liu Q, Horne A, et al. Assessment of tophus size: a comparison between physical measurement methods and dual-energy computed tomography scanning. J Clin Rheumatol. 2012;18(1):23–7. A prospective study comparing physical measurement of tophi with DECT measurement of urate volume. DECT reproducibility was higher than that of physical measurement. Analysis of the DECT images also revealed variable deposition of urate within tophi of similar sizes.PubMedCrossRef
24.
go back to reference Bacani AK, McCollough CH, Glazebrook KN, Bond JR, Michet CJ, Milks J, et al. Dual energy computed tomography for quantification of tissue urate deposits in tophaceous gout: help from modern physics in the management of an ancient disease. Rheumatol Int. 2012;32(1):235–9.PubMedCrossRef Bacani AK, McCollough CH, Glazebrook KN, Bond JR, Michet CJ, Milks J, et al. Dual energy computed tomography for quantification of tissue urate deposits in tophaceous gout: help from modern physics in the management of an ancient disease. Rheumatol Int. 2012;32(1):235–9.PubMedCrossRef
25.
go back to reference Dalbeth N, Clark B, Gregory K, Gamble G, Sheehan T, Doyle A, et al. Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography. Ann Rheum Dis. 2009;68(8):1290–5.PubMedCrossRef Dalbeth N, Clark B, Gregory K, Gamble G, Sheehan T, Doyle A, et al. Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography. Ann Rheum Dis. 2009;68(8):1290–5.PubMedCrossRef
26.
go back to reference Dalbeth N, Milligan A, Doyle AJ, Clark B, McQueen FM. Characterisation of new bone formation in gout: a quantitative site-by-site analysis using plain radiography and computed tomography. Arthritis Res Ther. 2012;14(4):R165.PubMedCrossRef Dalbeth N, Milligan A, Doyle AJ, Clark B, McQueen FM. Characterisation of new bone formation in gout: a quantitative site-by-site analysis using plain radiography and computed tomography. Arthritis Res Ther. 2012;14(4):R165.PubMedCrossRef
Metadata
Title
Dual-Energy Computed Tomography for Gout Diagnosis and Management
Authors
Nicola Dalbeth
Hyon K. Choi
Publication date
01-01-2013
Publisher
Current Science Inc.
Published in
Current Rheumatology Reports / Issue 1/2013
Print ISSN: 1523-3774
Electronic ISSN: 1534-6307
DOI
https://doi.org/10.1007/s11926-012-0301-3

Other articles of this Issue 1/2013

Current Rheumatology Reports 1/2013 Go to the issue

CHRONIC PAIN (LJ CROFFORD, SECTION EDITOR)

Personalized Treatment of Pain

CHRONIC PAIN (LJ CROFFORD, SECTION EDITOR)

Effect and Treatment of Chronic Pain in Inflammatory Arthritis

SCLERODERMA (J VARGA, SECTION EDITOR)

Morphogen Pathways in Systemic Sclerosis

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine